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EFFECT OF HIV INFECTION AND PREGNANCY ON PARAMETERS OF 
VAGINAL IMMUNITY  
ANDREW VALLEJO 
ABSTRACT 
The female genital tract is a mucosal epithelium that has an array of factors 
contributing to the cervicovaginal immune environment. Like with systemic immunity, 
innate and adaptive immune mediators are integrated in the efficiency for fighting 
infections in the female genital tract. Our study addresses the role of pregnancy and HIV 
infection on concentrations of cytokines in genital tract fluid that play a role in HIV 
sexual transmission. We focused on two pathways:  The NF-KB inflammation pathway 
that has been implicated in susceptibility to HIV infection, and two interferon pathways 
that have been associated with antiviral immune defense. We hypothesized that pregnant 
women have increased proinflammatory cytokines in genital secretions, potentially 
putting them at increased risk for HIV infection, and that HIV-infected women could 
have upregulated Type 1 interferon pathways that may regulate HIV replication in the 
genital tract, and infection by other viruses. 
This study compared the immune mediator profiles in genital secretions of 
women between the ages of 18 and 40 years old belonging to four groups: HIV Negative/ 
Non Pregnant, HIV Negative/Pregnant, HIV Positive/ Non Pregnant, and HIV positive/ 
pregnant. Cytokine concentrations in cervicovaginal lavage fluid were measured using 
ELISA and MAGPIX assays. A number of statistical methods were used to characterize 
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cytokine pathways and to link pathway associated cytokines to HIV serostatus and/or 
pregnancy.  
The study showed that HIV positive women had higher levels of proinflammatory 
cytokines including IL-1α,	IL-2RA,	IL-4,	IL-5,	IL-6,	IL-7,	IL-12,	IL-17,	MIF,	MIG,	MIP-1ß,	SCGF,	TNF-α,	and	TRAIL.	Only	the	antimicrobial	peptide	lysozyme	was	significantly	decreased	in	HIV	positive	women.	However,	lysozyme	was	significantly	increased	in	pregnant	women	where	as	the	following	cytokines	were	significantly	decreased	in	pregnant	women:	ß-NGF,	G-CSF,	GM-CSF,	GRO-α,	HGF,	IGN-α2,	IFN-γ,	IL-2RA,	IL-3,	IL-4,	IL-6,	IL-7,	IL-12,	IL-13,	IL-16,	IL-17,	TNF-α,	TRAIL. The correlation 
analysis showed that HIV positive nonpregnant women could have upregulated: NFκB, 
type I interferon and interferon-γ pathways. The correlation analysis showed that the 
NFκB pathway could be upregulated in pregnant HIV negative women and these findings 
suggest that vaginal inflammation may play a role in HIV transmission from HIV-
infected women to uninfected pregnant women. Moreover, upregulated interferon 
pathways could help understand how the body regulates genital viral infections in HIV-
infected women. 
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INTRODUCTION 	
 The immune system can be explained in various fashions. One common approach 
to describing the immune system is by distinguishing between innate and adaptive 
immunity. Innate immunity can be considered the first line of defense after the physical 
barriers, and adaptive can be considered the specialized immune response. We will 
review the method of communication between the innate and adaptive. Although the 
immune system is a very complex and interdependent system the classification into these 
two groups facilitates the understanding. We will also cover broadly the Human 
Immunodeficiency Virus (HIV) and finally go into depth with what is currently 
understood of immunity in the female genital tract in relation to hormone regulation, 
sexually transmitted infections (STIs) and microbiota. 
Innate immunity 
 The first defense against pathogens is the physical barriers formed by our skin and 
mucosal epithelial layers. Once bypassing the physical barriers a pathogen will trigger a 
non-specific defense response from the innate immune system. There are two methods 
that innate immunity uses to fight infections, an inflammatory response and an antiviral 
defense (Abbas, Lichtman, and Pillai 2014). Inflammation plays a pivotal role in altering 
epithelium and endothelial layers to allow the penetration of leukocytes into the infected 
tissue. Cellular agents such as macrophages and dendritic cells digest pathogens via 
phagocytosis. Aside from their primary role in fighting microorganisms macrophages 
release chemical messengers, cytokines, to recruit neutrophils commonly circulating in 
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the blood (Delves, Martin, and Burton 2011). These chemical messengers will begin a 
signaling cascade that enables neutrophils to penetrate through the vasculature into the 
tissue to attack the pathogen. This process is depicted in Figure 1 below. 
 
Figure 1 Sequence of events in migration of blood leukocytes to sites of infection. At 
sites of infection, macrophages, dendritic cells, and other cells that have encountered 
microbes produce cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1) 
that activate the endothelial cells of nearby venules to express selectins and ligands for 
integrins, and to secrete chemokines. Selectins mediate weak tethering and rolling of 
blood neutrophils on the endothelium, integrins mediate firm adhesion of neutrophils, and 
chemokines activate the neutrophils and stimulate their migration through the 
endothelium to the site of infection. Blood monocytes and activated T lymphocytes use 
the same mechanisms to migrate to sites of infection. (Abbas, Lichtman, and Pillai 2014) 
 
Macrophages use their toll-like and scavenger receptors to initiate inflammation by 
detecting lectins, lipoproteins, foreign protein, oligonucleotides, polysaccharides, and 
other molecules. The macrophages use cytokines such as TNF, IL-1, IL-6, IL-8, and IL-
12 to elicit the inflammatory immune response. Along with these cytokines macrophages 
	3 
also secrete chemokines, which are involved in aiding immune cells to migrate towards 
the infected region. The cytokines such as tumor necrosis factor (TNF), and interleukins 
(IL) elicit inflammatory responses by interacting with cell surface receptors on immune 
cells. These receptors signal the activation of transcription factors that stimulate the 
inflammatory immune function. The NFkB is a family of transcription factors that 
regulate immune and inflammatory responses through gene expression that controls 
cellular differentiation, proliferation, and cooridinate innate and adaptive immune 
function (Mitchell, Vargas, and Hoffmann 2016). The NFκB pathway can be activated 
through TLRs, IL-1R, and TNF-R (Verstrepen et al. 2008). Figure 6 shows the possible 
ligands and their corresponding receptors cascading a signal to stimulate the NFκB 
transcription factors.  
Colony stimulating factors (CSFs) promote the production of neutrophils in the 
bone marrow during times of infection. Neutrophils are recruited from the plasma into 
infected tissue to aid the innate immune response via phagocytosis of microbes and 
destruction of them in intracellular vesicles. (Abbas, Lichtman, and Pillai 2014) 
To prevent an excess of inflammation that could cause more harm than good, 
macrophages also secrete anti-inflammatory cytokines: IL-10, and TGF-ß (Arango Duque 
and Descoteaux 2014).  
	 4 
		
Figure 2. The NFκB Pathway. Cytokines associated with activating this immune 
pathway: Growth factors, Tumor necrosis factors, and interleukin 1 ligands. 
(SABIOSCIENCES 2012b) 
 
Aside from the aforementioned classical activation of macrophages there is an 
alternative method to activate macrophages.  Macrophages are derived from naïve 
monocytes that are circulating in the blood.  When the monocytes are exposed to TH1 
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alternative method to activate macrophages. Macrophages are derived from naïve 
monocytes which are circulating in the blood. When the monocytes are exposed to TH1 
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cytokines, IFN-γ, TNF, or LPS, they are selected to become M1 macrophages. The M1 
macrophages are proinflammatory, increase tumor suppression, have antimicrobial 
properties, and promote the TH1 response. When monocytes are exposed to IL-4 and IL-
13 the cell is polarized toward M2a macrophages. When monocytes are exposed to a 
combination of LPS, immune complexes, apoptotic cells, and IL1Ra the cell is polarized 
towards M2b, and when they are exposed to IL-10, TGF-ß, and glucocorticoids the cell is 
polarized towards M2c. The alternative pathways serve to promote TH2 response, 
promote wound healing and tissue repair, increase immunosuppression, and increase 
tumor protection/ proliferation (Arango Duque and Descoteaux 2014).  
 
Figure 3. Monocytes can become phenotypically distinct macrophages. Upon 
encountering different stimuli, monocytes turn into highly microbicidal (M1), or into 
	6 
immunosuppressive macrophages (M2). Stimuli can range from microbial substances to 
biochemical signals provided by the microenvironment of a given tissue. Many of the 
cytokines that bias macrophage phenotype are provided by surrounding lymphocytes or 
other non-immune cells. Macrophage subtypes release a vastly different array of 
cytokines and chemokines that can either promote inflammation and sometimes tissue 
destruction, or wound healing and tissue repair. M1 macrophages are known to be tumor 
suppressive whereas M2 macrophages generally promote tumorigenesis. It is important to 
note that macrophage bias is a spectrum and is reversible. IC, immune complexes; ApC, 
apoptotic cells; Gluc, glucocorticoids. (Arango Duque and Descoteaux 2014) 
 
The dendritic cells (DC) communicate with the adaptive immune system by 
secreting cytokines, once they have acquired a protein antigen of a microbe. Dendritic 
cells are located in epithelial regions as well as in peripheral lymphoid organs. The 
dendritic cell can be classified into two groups: conventional and plasmacytoid. The 
plasmacytoid dendritic cells are the main source of type I interferon for the innate 
immune system during viral infections; they can be found in blood and tissue. The 
conventional dendritic cell is commonly found in the epithelial tissue sampling the 
environment for microbial proteins. The convention dendritic cell serves a very important 
role in initiating the adaptive immune response, which we will further discuss in the 
adaptive immunity section. (Abbas, Lichtman, and Pillai 2014)  
Along with the cellular response, the complement system mediates attacks on 
harmful microorganisms. Three different methods are known to activate the complement 
system. One is antibody dependent and the other two are antibody independent, all three 
ultimately elicit the formation of the terminal complement complex “either as sC5b-9, or 
as pore-like membrane attack complex (MAC)” (Mamidi, Hone, and Kirschfink 2015). 
Mamidi also illustrates a pro-inflammatory state resulting from complement system 
activation. This inflammation is nonspecific and causes unwanted damage to healthy 
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pathogen-free tissue highlighting the innate immunity’s lack of precision and specificity 
for its target.  
In some cases, pathogens invade host cells, where they hide very well from the 
complement system and macrophages. In this case the innate immune system uses 
plasmacytoid dendritic cells and macrophages to produce cytokines that enhance the 
function of natural killer (NK) cells (Delves, Martin, and Burton 2011). NK cells destroy 
cells that are infected by intracellular bacteria, viruses, or cells that have DNA damage by 
releasing its cytoplasmic granules in proximity of the cell. (Abbas, Lichtman, and Pillai 
2014)  
 There exists another line of defense mediated by antimicrobial peptides (AMP) 
that directly destroy microbes and alter the environment to ideal conditions for immune 
responses. AMPs are small proteins, derived from epithelial cells and phagocytic cells 
that are secreted into the extracellular space to fight bacteria, viruses, fungi, and protozoa 
[hence why they are known as endogenous antibiotics]. Common AMPs include SLPI, 
lysozyme, defensins, cathelicidins, Elafin, HE4, lactoferrin, and MIP-3α. (Yarbrough, 
Winkle, and Herbst-Kralovetz 2015)  
Adaptive immunity 
As the innate immune system works to eliminate and contain pathogens, another 
purpose it serves is to alert the initially slow responding adaptive immune system. The 
adaptive immune system usually takes several days to respond to an unknown pathogen. 
The benefit of this attack is that it is highly specific to the pathogen and it improves with 
every exposure (Delves, Martin, and Burton 2011). The adaptive immune system is 
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highly dependent on the cells of the innate immune system for regulation; the primary 
mode of communication is via cytokines and chemokines.  
Like the innate branch the adaptive branch has its own specialized cells: effector 
cells (B and T lymphocytes), and antigen presenting cells (macrophages and dendritic 
cells). Dendritic cells (DC), like macrophages, sample the tissue environment for 
unknown entities. When a DC comes in contact with pathogen-associated molecular 
patterns (PAMPs) they go from a quiescent state to an activated state and travel to the 
surrounding lymph nodes to activate naive T-cells. The lymph nodes are where the naive 
T cells await activation for specialization towards a pathogen. The dendritic cells present 
the antigen to the naïve T-cell via the peptide-MHC receptor and T-cell Receptor (TCR) 
complex, Signal One. After Signal One is complete, a co-stimulatory signal between B7 
and CD28 on the DC and T-cell respectively must be accomplished for the T-cell to 
move on to clonal expansion. This mechanism ensures that the T-cell will be specific to 
the pathogen alone and not mistake host cells for pathogen. (Delves, Martin, and Burton 
2011)  
The form in which T cells kill pathogens is through CD8+ and CD4+ T cells. 
Some differences in activation between the two cells are: (1) activation of CD8+ T cell 
sometimes requires dendritic cells to cross-present the antigen, (2) the complete 
maturation into cytotoxic T cells and memory T cells sometimes requires co-activation of 
CD4+ T cells (Abbas, Lichtman, and Pillai 2014). Once stimulated, clonal expansion of 
antigen specific T cells takes about 1 to 2 days to occur, and once accumulated the 
effector cells begin to fight the infection. The CTL combat infection through direct 
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contact with the infected cells. In contrast CD4+ effector cells, helper T cells, use 
cytokines to promote other effector cells such as macrophages, PMN lymphocytes, or B 
lymphocytes. The stimulation of B lymphocytes leads to the secretion of antibodies 
accounting for the humoral immunity arm of the adaptive immune response. (Abbas, 
Lichtman, and Pillai 2014) 
 
Figure 4. Characteristics of subset of CD4+ helper T lymphocytes. A naive CD4+ T 
cell may differentiate into subsets that produce different cytokines and perform different 
effector functions. The table summarizes the major differences among TH1, TH2, and 
TH17 subsets of helper T cells. Note that many helper T cells may not be readily 
classified into these distinct, polarized subsets. IFN, Interferon; Ig, immunoglobulin; IL, 
interleukin. (Abbas, Lichtman, and Pillai 2014) 
Cytokines 
As the immune cells are alerted to the presence of pathogens, immune cells 
release small proteins called cytokines into the extracellular space. Aside from 
macrophages and T cells, previously illustrated, cytokines can be secreted by 
polymorphonuclear (PMN) leukocytes, endothelial cells, epithelial cells, adipocytes, and 
connective tissue (Arango Duque and Descoteaux 2014). Cytokines vary depending on 
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the cell and the stimulus on the cell. A paradigm exists in cytokine mechanisms: a single 
cytokine can elicit different responses and can be produced by different cells (Hiscott and 
Ware 2011). Cells are capable of expressing several receptors for a specific cytokine and 
multiple cytokines can elicit the same response (Arango Duque and Descoteaux 2014). 
Here we will explore the different classifications of cytokines, their cellular origin and try 
to understand broadly what role they play in different immune responses. Cytokines are 
released by immune cells and act on the cytoplasm of effector cells to transduce a signal 
and ultimately elicit an immune response (Modrow et al. 2013). Once released into the 
extracellular space, cytokines can act on the cell that emitted it, can act on neighboring 
cells, or travel farther and interact with cells in other areas in the body; these are known 
as autocrine, paracrine, and endocrine respectively (Arango Duque and Descoteaux 
2014). The major families of cytokines are Interleukins, Interferons, Tumor Necrosis 
Factors, colony-stimulating factors and chemokines.  
Interleukin Family 
Discovered in 1976 as a T-cell growth factor in supernatants of activated T-cells 
(Hiscott and Ware 2011), they are numbered according to when they were discovered 
(Modrow et al. 2013). They have a wide variety of functions listed in the table below. 
Table 1: Function, properties and activities of interleukins 
Interleukin Molecular 
Characteristics 
Receptor Producer Main 
Function 
IL-1 (IL-1 
alpha, 
IL-1beta) 
17 kDA CD121a/IL1R1 
(CD121b/IL1R2) 
Macrophages, 
Monocytes, 
Endothelial and 
Epithelial  
Cells 
B-,T-, and NK-
cell activation, 
induction of 
fever via 
hypothalamus 
IL-2 (T cell 
growth factor) 
15.4 kDA, 
O-glycosylated 
CD25/IL2R𝛼 
CD122/IL2R 
T cells T-cell 
proliferation/ 
activation 
	11 
IL-3 15-17 kDa CD123.IL3R𝛼 
CD131/IL3Rß 
B and T cells, 
Macrophages 
Endothelial 
Cells 
Growth factor 
for stem cells, 
important for 
haematopoiesis 
 
IL-4 20 kDa, N-
glycosylated 
CD124/IL4R 
CD132/IL2Rγ 
TH2 cells, 
Mastocytes 
B-cell activation, 
switch to IgE 
synthesis, anti-
inflammatory 
IL-5 20 kDA 
homodimer, N-
glycosylated 
CD125/IL6Rα 
CD131/IL3Rß 
TH2 cells, 
Mastocytes 
Growth and 
differentiation of 
eosinophils, 
chemotactic for 
eosinophils 
IL-6 21.5-28 kDa, 
glycosylated, 
phosphorylated 
CD126/IL6Rα 
CD130/IL6Rß 
Macrophages 
T cells 
Induction of 
synthesis and 
release of acute-
phase proteins in 
hepatocytes, 
proinflammatory 
IL-7 17.4 kDa CD127/IL7Rα 
CD132/IL2Rγ 
Bone marrow 
stromal cells 
Proliferation of 
precursor cells of 
B and T cells, 
proinflammatory 
IL-9 
(mastocyte 
growth 
factor) 
14 kDa, 
N-glycosylated 
CD129/IL9R TH cells Proliferation of 
mast cells 
IL-10 30 kDa, 
homodimer 
CD210/IL10Rα 
CDw210B/IL10Rß 
Th2 cells 
CD8+ T cells 
Macrophages 
Monocytes 
Inhibits 
macrophages, 
inhibits TH1 
cells, anti-
inflammatory 
IL-11 23 kDa IL10Rα Bone marrow 
Stromal cells 
Induction of 
synthesis and 
release of acute-
phase proteins in 
hepatocytes, 
induction of 
proliferation in 
haematopoietic 
precursor cells 
IL-12 70 kDa, 
heterodimer of 
40kDa (IL-12 –
p40) and 35 kDa 
(IL-12 –p35), 
glycosylated 
CD212/IL12Rß1 
CD212/IL12Rß2 
B and T cells 
Dendritic 
Cells 
Macrophages 
Induction of 
differentiation of 
CD4+ 
T cells, 
activation of NK 
cells, stimulates 
the production of 
IFN-γ 
IL-13 13 kDa  IL13R Th2 cells 
Mast cells 
Proliferation and 
differentiation of 
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NK cells B cells, 
Inhibits synthesis 
of 
proinflammatory 
interleukins of 
macrophages 
IL-15 14 kDa, 
glycosylated 
IL-15Rα Mononuclear 
Phagocytes 
Macrophages 
Proliferation of 
mastocytes and 
NK cells 
IL-17 30 kDa, 
homodimer, 
glycosylated 
CDw217/IL17Rα 
CDw217/IL17Rß 
CD4+ T cells Production of 
proinflammatory 
cytokines in 
endothelial cells 
as well as 
fibroblasts 
IL-18 18 kDa  CDw218a/IL18R1 Macrophages 
Monocytes 
Dendritic cells 
Proinflammatory 
NK	natural	killer,	TH	T	helper	*Receptor	are	indicated	according	to	the	CD-nomenclature,	as	far	as	known,	and	the	alternative	designation	
(Modrow et al. 2013) 
Interferon Family 
 Type I interferons (IFN), IFN-α and IFN-ß, are prevalent when the immune 
system is fighting a viral infection. Type I IFNs inhibit cell division, and increase the 
expression of MHC type I – antigens, which are used in presenting viral antigens (Delves, 
Martin, and Burton 2011). Type I IFN also promotes synthesis of pro-apoptotic proteins 
and suppresses the expression of anti-apoptotic factors. Type II IFN is known as IFN 
gamma and its main effect is to promote the expression of MHC II-antigen complex. 
(Modrow et al. 2013). MHC II –antigens alert the immune system of extracellular 
pathogens via phagocytotic cells (Delves, Martin, and Burton 2011). Several viral 
pathogens have developed ways of bypassing the interferon-mediated immune response. 
Examples include the Herpes simplex virus which inhibits antigen presentation so that the 
virus goes undetected by CTLs, the Pox virus which promotes the production of soluble 
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cytokine receptors to dampen the effects of IFN-γ on activating macrophages (Abbas, 
Lichtman, and Pillai 2014), and HIV which infects the IFN producing cells ultimately 
using the bodies own immune system to proliferate (Arnold et al. 2016). 
 
Figure 5. Interferon Pathway. Signal cascade initiated by IFN-α, IFN-ß, and IFN-γ 
(SABIOSCIENCES 2012a) 
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TNF family 
 The two main cytokines in the TNF family that have been well studied are TNF-α 
and TNF-ß. TNF-α is a proinflammatory cytokine released by DC, macrophages, and B-
cells;  both TNF α and ß are released by T lymphocytes (Modrow et al. 2013). TNF 
interacts with TNF receptors on cell membranes and induces a signal cascade that 
ultimately activates NFκB- associated genes (Modrow et al. 2013) leading to promotion 
and transcription of other cytokines necessary in an immune response (Abbas, Lichtman, 
and Pillai 2014). TNFs also induce immune cells such as macrophages to release more 
TNF coupled with IL-1, another proinflammatory cytokine, and oxygen radicals that 
directly fight pathogenic microbes. Some of the other systemic effects occur in the 
hypothalamus to stimulate the secretion of corticotropic releasing hormone, suppress 
appetite and cause a fever. TNF also causes vasodilation and increased vascular 
permeability, which facilitates the recruitment of monocytes and PMN lymphocytes to 
tissues. 
Chemokines 
Chemokines are a family of heparin-binding cytokines that guide immune cells to the 
cells that secreted the guiding chemokine; this process is known as chemotaxis. These 
special cytokines are usually released during a proinflammatory state. (Arango Duque 
and Descoteaux 2014) 
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 Table 2: Chemokine Characteristics 
Chemokine Producer Main Purpose 
MIP-2α (macrophage 
inflammatory protein 2α) 
Monocytes, and 
macrophages 
Recruitment of neutrophil, 
and hematopoietic stem 
cells* 
RANTES T-cells Inflammatory 
chemoattractant for T 
cells, basophils, 
eosinophils, dendritic cells 
Activation of NK cells* 
IL-8 Macrophages Recruitment of 
neutrophils, keratinocytes, 
endothelial cells, 
eosinophils, and 
basophils* 
MIG Induced by IFN-γ producing 
cells 
Recruitment of necessary 
cells for inflammation and 
repair of tissue damage, 
inhibits 
neovascularization, has 
anti-tumor and anti-
metastatic effects* 
IP-10 Monocytes, fibroblast, 
endothelial cells and 
macrophages 
Attracts T cells, NK cells, 
dendritic cells, and also 
has potent anti-cancer 
activity* 
IP-9 Monocytes, macrophages T cell recruitment, inhibits 
angiogenesis and tumor 
formation* 
*(Arango Duque and Descoteaux 2014) 
Antimicrobial Peptides 
Table 3: Antimicrobial peptides 
Antimicrobial Peptide Origin Effect 
HNP 1-3 (α-Defensins) Neutrophil primary 
granules,NK cells, 
monocytes, 
Found in vaginal mucosal 
epithelia 
Microbicidal, and 
cytotoxic 
SLPI Secreted by mast cells, 
neutrophils, and 
macrophages. Found in 
Potent protease inhibitor  
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cervical mucosa 
Lactoferrin Secondary granules of 
neutrophils, also secreted by 
acinar cells, found in breast 
milk 
Bactericidal, and 
fungicidal, also serves as a 
chelator 
LL-37 Neutrophils, monocytes, 
NK cells, mast cells. 
Expressed from the 
endometrium 
Bactericidal, cytotoxic 
IFN-ß Produced by fibroblasts Increase MHC class I 
antigens, inhibits MHC 
class II antigens stimulated 
by IFN-γ, activates T 
suppressor cells. 
Lysozyme Found in primary, 
secondary, and tertiary 
granules of neutrophils. 
Bactericidal 
(Yarbrough, Winkle, and Herbst-Kralovetz 2015) 
Cytokine role in HIV suppression  
 HIV positive patients have been found to produce antibodies and cytotoxic T cells 
against the viral antigens (Abbas, Lichtman, and Pillai 2014). The early increase in viral 
load is dampened by this immune response but the proliferation of the disease is not 
addressed with this response. A study comparing HIV positive and negative women, 
within commercial sex worker individuals, found that IFNα was higher in HIV positive 
women (Hirbod et al. 2006). The bodies natural defense against viral pathogens is 
through type I interferons. When a macrophage has phagocytosed a viral pathogen TLR’s 
found in the endosomes begin a signal cascade that triggers the production of IFN-α. The 
role of IFN-α in antiviral activity is multifold. They bind to IFN-α receptors on the 
infected cell and surrounding cells and prevent cell division, promote apoptotic factors 
such as TRAIL (Manches, Frleta, and Bhardwaj 2014), increase MHC class I expression 
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of cervical epithelial cells (Hirbod et al. 2006). However, the HIV virus inhibits the 
expression of MHC class I molecules making it difficult to recruit CTLs to kill infected 
cells(Abbas, Lichtman, and Pillai 2014). Moreover, if the CTLs are successful in killing 
the infected cells, the dead cell would be phagocytosed by macrophage thus further 
infecting the immune cells(Abbas, Lichtman, and Pillai 2014).  The paradoxical 
promotion of HIV infection through IFNα can also be seen in dendritic cells in the figure 
below. 
 
Figure 6. Conflicting role of DC in HIV infection. cDC and pDC both contribute to 
elimination of HIV infected cells, but at the same time participate to the 
immunopathology of HIV infection. cDC and potentially pDC, can cross-present HIV 
antigens to CD8+ T cells, leading to the differentiation of cytotoxic T cells. DC and NK 
cell cross-talk, through the secretion of inflammatory cytokines or type I IFN, can 
stimulate NK cell activation and elimination of HIV-infected cells. Type I IFN also acts 
directly on infected cells to trigger cell-intrinsic antiviral pathways, or can induce 
TRAIL-induced apoptosis through TRAIL expression on CD4+ T cells (not depicted). 
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On the other hand, DC play an active role in the pathological immune activation observed 
in chronic HIV infection. In addition to trans-infection, inflammatory cytokines and type 
I IFN contribute to alteration of Th17 and Treg frequencies in the gut, in part through 
expression of immunoregulatory enzyme (indoleamine 2,3 dioxygenase is depicted here), 
facilitating microbial translocation and chronic stimulation of Toll-like receptors or other 
pattern-recognition receptors by viral or bacterial products. Persistent inflammatory 
cytokines and IFN secretion can also augment central memory CD4+ T cell (TCM) 
proliferation and differentiation, leading to exhaustion of the CD4+ T cell pool, while at 
the same time generating increased target cell numbers for HIV infection. Type I IFN 
also induces the expression of immunosuppressive molecules (PDL-1) at the surface of 
DC, leading to diminished anti-viral immune responses. (Manches, Frleta, and Bhardwaj 
2014) 
A study assessing differences in infectivity of target cells between pregnant and 
non pregnant women found that SLPI, Elafin, MIP-3alpha, HBD2 were associated with 
anti-HIV activity (Anderson et al. 2012). There was a significant difference in 
concentration of these cytokines between pregnant and non pregnant women’s CVLs. 
Similarly a study exploring cell free HIV in seminal plasma showed that SLPI, 
lactoferrin, defensins, and alpha/beta chemokines are associated with suppression of HIV 
infectivity in target cells (Politch, Marathe, and Anderson 2014). The role of cytokines in 
HIV infectivity is further exemplified by a small fraction of patients that have shown to 
control HIV progression due to a mutation in CCX5R chemokine receptor.  
 The epithelial barrier has been shown to be effective in preventing HIV 
acquisition; however, factors that alter this barrier could give HIV the opportunity to 
infect the body. Inflammation recruits immune cells to the cervical mucosa, which are the 
target cells of the HIV infection (Masson et al. 2014). Immune cells respond to 
inflammatory signals from innate immune cells and travel from vasculature and lymph 
nodes to sites of infection (Abbas, Lichtman, and Pillai 2014). Further evidence linking 
inflammation with HIV infectivity is exhibited in the positive association between 
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proinflammatory antimicrobial peptide, α-defensins, with HIV infectivity (Arnold et al. 
2016).  
Vaginal Immunity  	 The vaginal and cervical mucosa of the female genital tract offer a physical 
barrier of protection of infection by all types of pathogens. In addition, the female genital 
tract executes a number of immune defenses to protect against pathogens. These defenses 
are local and independent from those occurring in the systemic environment. Cytokine 
profiles observed in the female genital tract are different from the cytokines released in 
the plasma (Masson, Passmore, et al. 2015). Cytokine concentrations can be quantified in 
cervical vaginal lavages (CVL). Moreover, there are many factors that have been shown 
to alter baseline level of cytokine concentration across the population. A study 
investigated the differences in cytokine concentrations and vaginal microbiota 
populations between sexually active adolescent (ages 15-18) women and adult women 
(age 18 to 50). The study found that the group of sexually active adolescent women had 
significantly higher endogenous anti-HSV-2 activity, had significantly higher inhibition 
of viral plaque formation, and significantly lower endogenous anti-E.coli activity 
compared to the adult women (Madan et al. 2012). The study also showed that hormonal 
concentration had no significant change	in microbiota between the groups in question.  
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Figure 7 Anti-HSV and anti-E.coli activity for adolescent and adult cervical vaginal 
lavage (CVL). For anti-HSV activity, Vero cells were infected with HSV-2(G) mixed 1:1 
with each CVL specimen or control buffer. Viral plaques were counted after 48 hours and 
percent inhibition calculated relative to control. For E. coli bactericidal activity, 3 ml of 
stationary phase bacteria (,10
9 colony forming units[cfu]/ml) were mixed with 27 ml of 
each CVL specimen or control buffer and incubated at 37 uC for two hours. The mixtures 
were then further diluted in buffer to yield 800–1000 cfu in control specimens and plated 
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in duplicate on agar enriched with trypticase soy broth. Colonies were counted after an 
overnight incubation at 37uC and percent inhibition calculated relative to control. All 
samples were tested in duplicate in two independent experiments. The horizontal lines 
represent the median value for each group, compared by Mann Whitney U test. (Madan et 
al. 2012) 
 	 Madan et al. (Madan et al. 2012) measured cytokine concentrations using a 
Luminex multiplex proteome array with beads from Chemicon (Billerca, MA), and 
analyzed them with StarStation (Applied Cytometry Systems, Sacramento, CA. Their 
results showed a significant decrease in protein concentration in the young adolescent 
group. Therefore the cytokine concentrations were analyzed as both protein concentration 
and ml of CVL. Depending on which analysis method was used there were significant 
differences in cytokine concentrations between the two groups. When measured as per 
unit of protein there was a significance increase in IL-6 and IL1-alpha in the adolescent 
women. The concentration of antimicrobial and anti-inflammatory SLPI was lower in 
adolescent women when measured as per unit of volume. The significant difference in 
levels of SLPI and antimicrobial mediators was not present when corrected for protein 
content. Their study shows that the group’s respective CVL profiles could be associated 
with increased or decreased susceptibility to certain infection; however, the shifts of 
significance when correcting for protein concentration have not yet been fully explained. 
Microbiota plays a critical role in cervical immunity. The natural microflora in the 
cervicovaginal mucosa, lactobacilli, foster protection from pathogenic bacteria by 
secreting lactic acid and maintaining a low vaginal pH(Anderson et al. 2013). The low 
pH not only is favorable for Lactobacilli colonization but it also prevents other bacteria 
from invading (Mirmonsef et al. 2014). Mirmonsef also found that there was a strong 
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positive relationship between Lactobacilli presence and levels of free glycogen (r=0.48, 
p=0.001), which in turn are affected by estrogen levels.	
	
Table	4.	Concentration	of	soluble	immune	mediators	in	cervicovaginal	lavage	
samples	
	(Madan	et	al.	2012)	
Hormonal effects on the female reproductive tract  
 The menstrual cycle offers a consistent hormone fluctuating platform that aids in 
investigating progesterone and estradiol effects on the cervical mucosa. Studies on 
hormonal regulation of vaginal immunity have suggested that there is a window during 
the menstrual cycle where the immune system is slightly repressed to optimize 
fertilization (Wira et al. 2010). This immune suppression is attributed to the effects of 
two steroid hormones: progesterone and estradiol. Hormone fluctuations throughout the 
menstrual cycle have effects in the lower female reproductive tract, ectocervix and 
vagina. Wira and Fahey showed that high levels of estradiol coupled with progesterone, 
which occur after ovulation in the luteal phase of the menstrual cycle, decreased the TER 
(epithelial integrity) in the upper reproductive tract. This could increase susceptibility to 
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infection in the upper reproductive tract by increasing the permeability of the epithelium 
barrier (Wira et al. 2010). Throughout the menstrual cycle there are slight changes in the 
recruitment of macrophages, neutrophils, and B cells (Givan et al. 1997). There is also 
evidence of changes in cytotoxic T lymphocyte activity associated with hormone 
fluctuations through out the menstrual cycle (White et al. 1997). Women on combined 
oral contraception (COC), estrogen and progesterone, also exhibit elevated vaginal pro-
inflammatory responses. Endocervical swabs of women using COC have elevated IL-
1beta, IL-6, IL-8, VEGF, and IL-1RA. Along with pro-inflammatory cytokines, COC 
subjects also exhibit elevated anti-inflammatory cytokines: SLPI, beta-defensin-2, and 
ratio IL-RA:IL-1beta (Morrison et al. 2014). These studies support the claim that steroid 
hormones have immune modulatory properties in the cervical mucosa.  
 Pregnant women, who have elevated levels of progesterone and estrogen, have 
also been used to study the effects of hormones on immune function. In some studies, 
pregnancy has been shown to be associated with a pro-inflammatory state (Morrison et al. 
2014). However, levels of IL-6 and IL- 8 fluctuate throughout pregnancy (Donders et al. 
2003) adding to the difficulty in establishing a baseline in cytokine profiling. Other 
studies comparing pregnant and non-pregnant groups contradict the extent of the 
suggested pro-inflammatory state. Several inflammation-regulating cytokines, IL-10, 
SLPI, IL-4, GM-CSF, IFN-gamma, TNF-alpha, and MIP-1alpha, show no difference in 
concentration in cervical secretions from non-pregnant and pregnant women (Anderson et 
al. 2013).	
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 Vaginal immunity and HIV infection 
 In a study exploring HIV-1 infection and vaginal immune mediators (Anderson et 
al. 2012), IL-6, MCP-1, MIP-1alpha, Elafin, HBD-2, and MIP-3alpha all were 
significantly lower in pregnant women, when corrected for protein concentration 
(Anderson et al. 2012). Despite the different cytokine concentrations between pregnant 
and non-pregnant women the overall results concluded that both pregnant and non-
pregnant groups share similar activity in suppressing HIV-1 infectivity. Increased risk of 
HIV acquisition during pregnancy is also supported in a study where the serum of 10,000 
women was tested during pregnancy and post partum. The study assessed the incidence 
ratios of HIV acquisition pregnant by taking an interview and taking a blood serum 
sample to test for HIV. The study showed that the incidence rate ratio during pregnancy 
was 2.16 compared to 1.16 during post partum breastfeeding (Gray et al. 2005). The 
study also reported lower sexual risk behavior in the pregnant group despite the increase 
in incidence of acquisition. Gray attributed the incidence ratio to hormonal induced 
changes in the genital tract mucosa and immune response.  
 A recent study compared vaginal inflammatory profiles of HIV-negative and 
HIV-seroconverting women (Masson, Passmore, et al. 2015) CVL samples were taken at 
two different time points, and the study measured 12 cytokines: MIP-1alpha, MIP-1beta, 
GM-CSF, IL-7, IP-10, IL-8, IL-1alpha, MCP-1, IL-10, IL-6. The results showed that 
women who were infected with HIV between the points of collection, seroconverters, 
exhibited higher concentrations of MIP-1alpha, MIP-1beta, and IP-10.  The study also 
showed that the risk of acquiring HIV was significantly higher in women who had 
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elevated genital inflammatory cytokine profiles. Using a partial Least squares 
discriminant analysis the 12 cytokines used were able to predict with a 65% overall 
accuracy between HIV positive and negative patients. Masson concluded that MIP-
1alpha, MIP-1beta, IL-8, and IP-10 could be used in classifying between the two groups 
of women, and that there is an association between risk of HIV infection and elevated 
inflammatory cytokines. Moreover, Masson’s supplementary analysis showed that 11 of 
the 12 cytokines did not significantly differ in concentration between the two time points.  
Other studies have also shown that pro-inflammatory cytokine profiles can be 
associated with STI’s, even asymptomatic STI’s. Studies show that a profile of increased 
concentrations IL-1beta and decreased IP-10 in CVLs, both pro-inflammatory cytokines, 
predicted the presence of treatable STI’s (Masson, Arnold, et al. 2015). The cytokine 
profile correctly classified presence of BV in 75% of HIV-uninfected women, whereas 
only 15% of the women infected with an STI’s had vaginal discharge and none had 
genital ulceration. These data indicate that presence of an STI promotes a pro-
inflammatory state. The immune cell recruitment and destruction of the infected 
epithelial layers (Masson et al. 2014) are also consequences of inflammatory responses 
associated with increased risk of HIV acquisition. A similar profile of elevated IL-1beta 
is seen in pregnant women when compared to non- pregnant women, primarily during the 
first trimester (Anderson et al. 2013). We can use what is known from the heightened 
pro-inflammatory state in pregnancy to better understand enhanced HIV acquisition in 
this group.  
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A method for further understanding the role of vaginal immunity on HIV 
acquisition and transmission is studying diseases that alter the vaginal environment. 
Bacterial vaginosis (BV) in particular has been shown to increase the risk of both 
acquisition and transmission of HIV-1 between men and women (Cohen et al. 2012). The 
Lactobacillus species in the women’s lower genital microbiota has shown to offer 
protection towards acquisition of HIV (Anderson et al. 2013). There are conditions where 
lactobacilli colonies are altered that could leave women at risk of HIV acquisition. In 
table 3, Anderson shows that hydrogen peroxide producing strains are less abundant 
during the first trimester of pregnancy (70% compared to 100% in the non-pregnant 
group) and there was an even more significant difference in the post partum group (17%).  
Table	5.	Organisms	isolated	during	each	visit	
 
(Anderson et al. 2013) 
 
Low levels of Lactobacilli have also been associated with increased shedding of the HIV 
virus leading to higher risk of transmitting HIV to non-infected partners (Sha et al. 2005), 
helping support the theory that Lactobacilli promote a healthy vaginal environment. 
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Hypothesis 	 We	hypothesize	that	HIV	serostatus	will	be	positively	associated	with	NFκB	and	an	antiviral	state.	We	also	hypothesize	that	pregnancy	will	be	associated	with	an	up	regulated	NFκB	pathway	activation.		
Specific Aims 	 The	aims	of	study	are	twofold:	(1)	Compare	proinflammatory	cytokine	and	antimicrobial	peptide	concentrations	between	women	who	are	HIV	positive/negative,	and	pregnant/non-pregnant	(2)	Determine	whether	Type	I	interferon,	type	II	interferon	and	NFκB	pathways	are	associated	with	HIV	serostatus	and/or	reproductive	status.	
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METHODS (research-based) 
Subjects 	 Women recruited for the study were between 18 and 40 years of age. Pregnant 
women recruited were within 13 – 30 weeks of gestational age. The non-pregnant women 
had regular menstrual cycles for the last 3 months prior to enrollment. Women that were 
on hormonal contraception, other hormonal treatments, or IUDs were excluded from the 
study. Other exclusionary criteria included diabetes mellitus, hepatitis, gestational 
diabetes mellitus, chronic hypertension (requiring medication), active syphilis, herpes 
simplex lesions, antibiotics use within 2 weeks of CVL collection, planned termination of 
pregnancy, known fetal anomalies, and symptomatic vaginal discharge requiring 
treatment within two weeks of enrollment.  
Sample and Data Collection 
All women signed IRB-approved informed consent. A cervicovaginal lavage 
(CVL) was performed on all study participants while undergoing a routine speculum 
exam. Three ml of isotonic saline were introduced into the vaginal cavity, aspirated, and 
then repeated two more times using the same 3ml of saline.  
All CVLs were then transported to the lab within 4 hours and microscopically 
screened to ensure the absence of sperm, red blood cells, pathogens, and to quantify PMN 
using a peroxidase staining (Endtz 1974). The samples were then centrifuged and the 
supernatants were extracted and stored at -80 degrees C. IFN-ß and several antimicrobial 
peptides  (HNP1-3, LL-37, lysozyme, lactoferrin, and SLPI) were measured  by ELISA.  
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A MAGPIX 17-plex panel and a 21-plex panel (both from Bio-Rad) were used to 
quantify the following cytokines: IL-1ß, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-
12(p70), IL-13, IL-17, G-CSF, GM-CSF, IFN-γ, MCP-1(MCAF), MIP-1ß, TNF-α, IL-
1α, IL-2Rα, IL-3, IL-12(p40), IL-16, IL-18, CTACK, GRO-α, HGF, IFN-α2, LIF, MCP-
3, M-CSF, MIF, MIG, ß-NGF, SCF, SCGF-ß, SDF-1α, TNF-ß, and TRAIL. The assays 
were read on a Bio-Plex MAGPIX multiplex reader (Bio-Rad Laboratories, Inc., 
Hercules, CA, USA). The protein concentration was measured using a Pierce BCA 
Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). EnzyChrom Glycogen Assay 
Kit (BioAssay Systems, Hayward, CA, USA) was used to determine glycogen 
concentrations. 
Data Analysis 
The data were analyzed using SAS (SAS Institute, Inc., Cary NC, USA) and JMP Pro 11 
statistical software. The cytokines that satisfied requirements for parametric statistics 
were run in a two-factor ANOVA to test the effects of HIV serostatus and reproductive 
status (not pregnant and pregnant). For variables that did not meet requirements for 
parametric statistics, the data was log transformed prior to the ANOVA. Cytokines 
showing significant effects for either HIV serostatus or reproductive status by ANOVA 
were used in the following analysis. Cytokines were grouped depending on main effect 
with type I interferon pathway, type II interferon pathway, and the NF-κB pathway. The 
cytokines were placed in a correlation matrix using first Pearson correlation, and then 
Spearman correlation to treat for any non-parametric profiles. If a pathway was 
determined to be up-regulated or down-regulated in a subgroup, a partial least squares 
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discriminant analysis was performed to indicate the likelihood that HIV serostatus could 
be distinguished between subjects according to the pathway associated cytokines. The 
pregnant and non pregnant group subjects were separated in each analysis.  
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RESULTS 
ANOVA Findings 
The following results of the two factor ANOVA were assessed in concentration 
per ml of saline. The following cytokines were significantly increased in HIV positive 
women: ß-NGF, GRO-α, HGF, IFN-α2, IFN-γ, IL-1α, IL-2, IL2RA, IL-4, IL-7, IL-10, 
IL-12, IL-16, IL-17, MCP-3, MIF, MIG, MIP-1ß, SCF, SCGF, TNF-α, and TRAIL. 
TNF-ß was decreased in HIV positive women. The following cytokines were 
significantly increased in pregnant women: GM-CSF, IL-1α, lysozyme, SDF-1α. 
Pregnant women were found to have significantly decreased: GRO-α, IL-2, IL-7, MCP-1, 
and MIP-1ß.  
The following results are from a two factor ANOVA performed on the same data 
sample but analyzed as mg of protein instead of ml of saline. The two factor ANOVA 
revealed that protein concentration was significantly increased in the pregnant population 
(p< 0.0012). The following cytokines were found to share a positive association with 
HIV serostatus: ß-NGF, GRO-α, HGF, IFN-α2, IFN-γ, IL-1α, IL-2RA, IL-4, IL-5, IL-6, 
IL-7, IL-12, IL-13, IL-16, IL-17, MIF, MIG, MIP-1ß, SCF, SCGF, TNF-α, and TRAIL. 
Only the antimicrobial peptide lysozyme significantly decreased in HIV positive women. 
Lysozyme also showed a significant increase in pregnant women. The following 
cytokines had a significant decrease in concentration in pregnant women: ß-NGF, G-
CSF, GM-CSF, GRO-α, HGF, IGN-α2, IFN-γ, IL-2RA, IL-3, IL-4, IL-6, IL-7, IL-12, 
IL-13, IL-16, IL-17, TNF-α, TRAIL. Although there were significant findings when 
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adjusted for protein, the following results only include the volume adjusted analysis. The 
increase in protein concentration due to pregnancy introduces a confounding variable that 
skews the results when mg protein is used as the denominator. The pathway associated 
cytokines were used to construct correlation analysis for the four subgroups of women: 
HIV negative (HIV-)/Non Pregnant (NP), HIV positive (HIV-)/Pregnant (P), HIV positive 
(HIV+)/ non Pregnant (NP), HIV positive (HIV+)/Pregnant (P). 
Table 6 Summary of ANOVA determined relationships of cytokines with HIV 
serostatus and reproductive status. 
Variable HIV↑ HIV↓ Pregnancy↑ Pregnancy↓ 
PMN (x 105/ml)   X  
b-NGF (pg/ml) X    
GM-CSF (pg/ml)   X  
GRO-a (pg/ml) X*   X* 
HGF (pg/ml) X    
IFN-a2 (pg/ml) X    
IFN-γ (pg/ml) X    
IL-1a (pg/ml) X*  X  
IL-2 (pg/ml) X   X* 
IL-2RA (pg/ml) X    
IL-4 (pg/ml) X    
IL-5 (pg/ml)     
IL-7 (pg/ml) X   X 
IL-10 (pg/ml) X    
IL-12 (pg/ml) X    
IL-13 (pg/ml)     
IL-16 (pg/ml) X    
IL-17 (pg/ml) X    
Lysozyme (ng/ml)   X  
MCP-1 (pg/ml)    X 
MCP-3 (pg/ml) X    
MIF (pg/ml) X    
MIG (pg/ml) X    
MIP-1b (pg/ml) X*   X* 
SCF (pg/ml) X    
SCGF (pg/ml) X    
SDF-1a (pg/ml)   X  
TNF-a (pg/ml) X    
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TNF-b (pg/ml)  X   
TRAIL (pg/ml) X    
* 0.10 > p > 0.05 
(Politch 2014) 
NFκB Pathway 	 The	main	cytokines	known	to	be	associated	with	the	NFκB	pathway	are	IL-10,	IL-1α,	IL-1ß,	TNF-α,	SCGF,	and	HGF.	From	these	cytokines	IL-10,	IL-1α,	TNF-α,	and	SCGF	all	were	shown	to	increase	significantly	in	HIV	positive	women.	The	following	tables	illustrate	the	correlations	between	all	relevant	cytokines	in	the	NFκB	pathway	for	the	subgroups	HIV-/NP,	HIV-/P,	HIV+/NP,	HIV+/	P.	
Table 7. Correlation matrix : HIV Negative, Non Pregnant, per ml 
		 IL-1b	 IL-8	 IL-10	 IL-1a	 HGF	 SCGF	 TNF-b	 TNF-a	
IL-1b	 1.00	 0.80	 0.65	 0.44	 0.97	 -0.06	 -0.51	 0.97	
IL-8	 0.80	 1.00	 0.47	 0.72	 0.72	 -0.02	 -0.67	 0.81	
IL-10	 0.65	 0.47	 1.00	 0.36	 0.68	 -0.17	 -0.22	 0.71	
IL-1a	 0.44	 0.72	 0.36	 1.00	 0.34	 0.21	 -0.19	 0.46	
HGF	 0.97	 0.72	 0.68	 0.34	 1.00	 -0.06	 -0.50	 0.97	
SCGF	 -0.06	 -0.02	 -0.17	 0.21	 -0.06	 1.00	 0.05	 -0.10	
TNF-b	 -0.51	 -0.67	 -0.22	 -0.19	 -0.50	 0.05	 1.00	 -0.52	
TNF-a		 0.97	 0.81	 0.71	 0.46	 0.97	 -0.10	 -0.52	 1.00		Looking	specifically	at	the	HIV-/NP	CVLs	all	the	cytokines,	except	for	SCGF,	shared	a	correlation	of	at	least	50%	with	at	least	one	other	cytokine.	IL-1ß	and	IL-8	had	correlations	greater	then	50%	with	5	of	the	other	7	cytokines	in	the	analysis.		
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Table 8. Correlation matrix : HIV Positive, Non Pregnant, per ml 
		 IL-1b	 IL-8	 IL-10	 IL-1a	 HGF	 SCGF	 TNF-b	 TNF-a	
IL-1b	 1.00	 0.97	 0.11	 0.84	 0.76	 0.06	 -0.38	 0.51	
IL-8	 0.97	 1.00	 0.30	 0.78	 0.89	 0.11	 -0.48	 0.64	
IL-10	 0.11	 0.30	 1.00	 0.04	 0.68	 0.32	 -0.31	 0.90	
IL-1a	 0.84	 0.78	 0.04	 1.00	 0.58	 -0.01	 -0.24	 0.40	
HGF	 0.76	 0.89	 0.68	 0.58	 1.00	 0.23	 -0.56	 0.88	
SCGF	 0.06	 0.11	 0.32	 -0.01	 0.23	 1.00	 -0.44	 0.34	
TNF-b	 -0.38	 -0.48	 -0.31	 -0.24	 -0.56	 -0.44	 1.00	 -0.48	
TNF-a	 0.51	 0.64	 0.90	 0.40	 0.88	 0.34	 -0.48	 1.00	
 
Analyzing the correlation matrix of the HIV+/NP group showed a correlation of 97% 
between IL-1ß and IL-8. The remaining cytokines, except for SCGF, had a correlation 
greater than 50% with at least one other cytokine. HGF was correlated greater than 50% 
with every other cytokine except SCGF.  
Table 9. Correlation matrix : HIV Negative, Pregnant, per ml 
    IL-1b IL-8 IL-10 IL-1a HGF SCGF TNF-b TNF-a 
IL-1b 1.00 0.50 -0.15 0.94 0.95 0.00 -0.58 0.76 
IL-8 0.50 1.00 0.17 0.25 0.59 0.00 -0.66 0.76 
IL-10 -0.15 0.17 1.00 -0.22 -0.11 0.00 -0.15 0.24 
IL-1a 0.94 0.25 -0.22 1.00 0.88 0.00 -0.46 0.59 
HGF 0.95 0.59 -0.11 0.88 1.00 0.00 -0.66 0.82 
SCGF 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 
TNF-b -0.58 -0.66 -0.15 -0.46 -0.66 0.00 1.00 -0.69 
TNF-a 0.76 0.76 0.24 0.59 0.82 0.00 -0.69 1.00 
 
In the HIV-/P correlations, IL-10 had no correlation greater than 0.25 in magnitude. 
SCGF had no correlation with any other cytokine and the remaining cytokines shared a 
correlation greater than or equal to with at least 3 other cytokines. There were no 
detectable measures of SCGF for a majority of women in this group. 
 
	35 
Table 10. Correlation matrix: HIV Positive, Pregnant, per ml 
		 IL-1b	 IL-8	 IL-10	 IL-1a	 HGF	 SCGF	 TNF-b	 TNF-a	
IL-1b	 1.00	 0.99	 -0.39	 0.91	 1.00	 -0.06	 -0.27	 0.96	
IL-8	 0.99	 1.00	 -0.39	 0.88	 0.99	 -0.01	 -0.30	 0.96	
IL-10	 -0.39	 -0.39	 1.00	 -0.47	 -0.39	 0.67	 -0.26	 -0.15	
IL-1a	 0.91	 0.88	 -0.47	 1.00	 0.91	 -0.19	 -0.31	 0.83	
HGF	 1.00	 0.99	 -0.39	 0.91	 1.00	 -0.03	 -0.33	 0.96	
SCGF	 -0.06	 -0.01	 0.67	 -0.19	 -0.03	 1.00	 -0.66	 0.20	
TNF-b	 -0.27	 -0.30	 -0.26	 -0.31	 -0.33	 -0.66	 1.00	 -0.44	
TNF-a	 0.96	 0.96	 -0.15	 0.83	 0.96	 0.20	 -0.44	 1.00	
 
The HIV positive pregnant group, the correlations with respect to volume, resulted in 
cytokine concentrations with a correlation of 50% with at least one other cytokine.  
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Figure 8. Clustered correlation matrices for NFκB pathway (per ml concentrations). 
The following heat maps are of clustered correlation between cytokines involved in the 
NFκB pathway. The dark red indicates a perfect positive correlation (1), and the grey 
indicated a correlation coefficient of (0%), and dark blue indicates a perfect negative 
correlation (-1). A) Clustered correlation matrix of HIV negative/non pregnant subjects 
B) Clustered correlation matrix of HIV negative/pregnant subjects C) Clustered 
Correlation of HIV positive/ non pregnant subjects D) HIV positive/ Pregnant subjects 
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Using the clustered correlation heat maps, shifts in correlations between pregnant and 
non-pregnant groups are visually apparent. The emergence of a strong correlation of 
SCGF with IL-10 and TNF-ß is visible in the HIV positive, pregnant group. Also the 
presence of strong correlations between the majority of the NFκB associated cytokines is 
distinct in the HIV positive and negative, pregnant groups. 
 Using the nonparametric Spearman’s correlation analysis each group’s correlation 
was tested for significance. These following charts will verify whether the trends we 
witnessed in the previous analysis are significant or not.  
Table 11. Nonparametric: Spearman's ρ for HIV Negative, Non Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-8 IL-1b 0.9427 <.0001*  
IL-1a IL-1b 0.5971 0.0089*  
IL-1a IL-8 0.5937 0.0094*  
HGF IL-1b 0.8051 <.0001*  
HGF IL-8 0.7473 0.0004*  
HGF IL-1a 0.3945 0.1052  
TNF-a 
(#2) 
IL-1b 0.4591 0.0553  
TNF-a 
(#2) 
IL-8 0.4046 0.0959  
TNF-a 
(#2) 
IL-1a 0.2122 0.3979  
TNF-a 
(#2) 
HGF 0.4855 0.0411*  
TNF-b IL-1b  -0.6777 0.0020*  
TNF-b IL-8  -0.7186 0.0008*  
TNF-b IL-1a  -0.0950 0.7076  
TNF-b HGF  -0.6215 0.0059*  
TNF-b TNF-a 
(#2) 
 -0.2836 0.2540  
SCGF IL-1b 0.1637 0.5163  
SCGF IL-8 0.1169 0.6442  
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SCGF IL-1a 0.2572 0.3028  
SCGF HGF 0.2107 0.4014  
SCGF TNF-a 
(#2) 
 -0.2578 0.3017  
SCGF TNF-b 0.0702 0.7821  
IL-10 IL-1b 0.3176 0.1990  
IL-10 IL-8 0.2120 0.3984  
IL-10 IL-1a 0.4966 0.0360*  
IL-10 HGF 0.2165 0.3883  
IL-10 TNF-a 
(#2) 
0.5972 0.0089*  
IL-10 TNF-b 0.0724 0.7752  
IL-10 SCGF  -0.2108 0.4011  
 
The Spearman’s correlation analysis overall supported the trend highlighted in the 
Pearson correlation analysis of the HIV-/NP group. TNF-α however was borderline 
significance despite its strong correlation of 0.98 with HGF and it was on the cusp of 
being significantly correlated with IL-1ß despite its 0.97 correlation coefficient in the 
Pearson correlation analysis. The low correlations of SCGF with other cytokines are 
corroborated with lack of significance with other cytokines.  
Table 12. Nonparametric: Spearman's ρ for HIV Positive, Non Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ
| 
Plot 
IL-8 IL-1b 0.9173 <.0001*  
IL-10 IL-1b  -0.1244 0.6013  
IL-10 IL-8  -0.0754 0.7521  
IL-1a IL-1b 0.1865 0.4312  
IL-1a IL-8 0.0767 0.7479  
IL-1a IL-10  -0.1003 0.6741  
HGF IL-1b 0.8943 <.0001*  
HGF IL-8 0.9056 <.0001*  
HGF IL-10  -0.0136 0.9547  
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HGF IL-1a 0.1753 0.4599  
SCGF IL-1b 0.4803 0.0321*  
SCGF IL-8 0.5015 0.0243*  
SCGF IL-10 0.1336 0.5745  
SCGF IL-1a 0.0238 0.9208  
SCGF HGF 0.4712 0.0360*  
TNF-b IL-1b  -0.7595 0.0001*  
TNF-b IL-8  -0.8298 <.0001*  
TNF-b IL-10 0.2214 0.3481  
TNF-b IL-1a  -0.0166 0.9446  
TNF-b HGF  -0.7870 <.0001*  
TNF-b SCGF  -0.7056 0.0005*  
TNF-a 
(#2) 
IL-1b 0.7470 0.0002*  
TNF-a 
(#2) 
IL-8 0.7666 <.0001*  
TNF-a 
(#2) 
IL-10 0.1884 0.4264  
TNF-a 
(#2) 
IL-1a  -0.0023 0.9925  
TNF-a 
(#2) 
HGF 0.9013 <.0001*  
TNF-a 
(#2) 
SCGF 0.6587 0.0016*  
TNF-a 
(#2) 
TNF-b  -0.7569 0.0001*  
 
Although in the Pearson analysis IL-10 had strong correlations with HGF and TNF-α, 
according to the Spearman analysis of the HIV+/NP group IL-10 did not share 
correlations significantly greater than or less than zero. 
Table 13. Nonparametric: Spearman's ρ for HIV Negative, Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-8 IL-1b 0.8266 <.0001*  
IL-10 IL-1b 0.1798 0.4754  
IL-10 IL-8 0.2779 0.2642  
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IL-1a IL-1b 0.3932 0.1065  
IL-1a IL-8 0.3911 0.1085  
IL-1a IL-10 0.3946 0.1051  
HGF IL-1b 0.8493 <.0001*  
HGF IL-8 0.6726 0.0022*  
HGF IL-10 0.0432 0.8649  
HGF IL-1a 0.3347 0.1745  
SCGF IL-1b . .  
SCGF IL-8 . .  
SCGF IL-10 . .  
SCGF IL-1a . .  
SCGF HGF . .  
TNF-b IL-1b  -0.6987 0.0013*  
TNF-b IL-8  -0.6574 0.0030*  
TNF-b IL-10  -0.1560 0.5365  
TNF-b IL-1a  -0.3787 0.1212  
TNF-b HGF  -0.6185 0.0062*  
TNF-b SCGF . .  
TNF-a 
(#2) 
IL-1b 0.7650 0.0002*  
TNF-a 
(#2) 
IL-8 0.7909 <.0001*  
TNF-a 
(#2) 
IL-10 0.3870 0.1126  
TNF-a 
(#2) 
IL-1a 0.6118 0.0070*  
TNF-a 
(#2) 
HGF 0.7049 0.0011*  
TNF-a 
(#2) 
SCGF . .  
TNF-a 
(#2) 
TNF-b  -0.6284 0.0052*  
 
The cytokines in the HIV-/P group share significant correlations between all NFκB 
relevant cytokines except IL-1α, IL-10, and SCGF. IL-1α had a significant correlation 
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only with TNF-α. This contradicts the Pearson correlation analysis showing IL-1α 
having strong correlations with multiple cytokines.  
Table 14. Nonparametric: Spearman's ρ for HIV Positive, Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-8 IL-1b 0.6242 0.0537  
IL-10 IL-1b  -0.2195 0.5423  
IL-10 IL-8  -0.2988 0.4017  
IL-1a IL-1b 0.3455 0.3282  
IL-1a IL-8 0.4667 0.1739  
IL-1a IL-10  -0.4207 0.2260  
HGF IL-1b 0.6018 0.0656  
HGF IL-8 0.7234 0.0180*  
HGF IL-10  -0.0826 0.8206  
HGF IL-1a 0.6322 0.0498*  
SCGF IL-1b 0.3496 0.3221  
SCGF IL-8 0.3907 0.2643  
SCGF IL-10 0.5827 0.0771  
SCGF IL-1a  -0.2056 0.5687  
SCGF HGF 0.3713 0.2909  
TNF-b IL-1b  -0.5046 0.1369  
TNF-b IL-8  -0.6140 0.0590  
TNF-b IL-10  -0.3272 0.3561  
TNF-b IL-1a  -0.1763 0.6261  
TNF-b HGF  -0.7622 0.0104*  
TNF-b SCGF  -0.8560 0.0016*  
TNF-a 
(#2) 
IL-1b 0.5106 0.1315  
TNF-a 
(#2) 
IL-8 0.5471 0.1017  
TNF-a 
(#2) 
IL-10 0.3976 0.2553  
TNF-a 
(#2) 
IL-1a 0.1824 0.6141  
TNF-a 
(#2) 
HGF 0.6890 0.0275*  
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TNF-a 
(#2) 
SCGF 0.8044 0.0050*  
TNF-a 
(#2) 
TNF-b  -0.8384 0.0024*  
 
The HIV+/P group resulted in less significant correlation then anticipated by the Pearson 
analysis. HGF is correlated significantly with TNF-α, IL-8, IL-1a, and TNF-ß by SCGF 
are significantly correlated with each other. The Spearman fails to support the entire 
significant positive correlation depicted in the previous Pearson correlation analysis of 
the HIV+/P group of women. 
The following discriminant analysis will attempt to use the NFκB associated 
cytokines to distinguish subjects HIV serostatus besides on their cytokine profile. Since 
the ANOVA shows that several cytokines are also associated with pregnancy, the 
analysis will analyze the pregnant and non pregnant groups independently. The table 
below will visually depict HIV negative women in red circles and HIV positive women in 
blue triangles. The lines create boundaries attempting to group subjects into distinct 
groups. The main group of concern is the distinguishing between HIV serostatus, the 
other groups uses the association of the cytokines with each other to classify the subject 
within each group. A vertical line, not shown, crossing the point of intersection can be 
used to mark which subjects are classified as HIV negative or positive. The likelihood 
percentage measures the probability that the model would misclassify the subject’s HIV 
serostatus. The Predicted by Actual Ratio reports the ratio within either HIV positive or 
negative group. This ratio shows how many subjects HIV positive or HIV negative group 
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were correctly labeled into their respective group compared to the total number of 
subjects found in that group.  
Table	15:	Discriminant	analysis:	Likelihood	of	HIV	classification	by	NFkB	
pathway,	concentration	per	ml 
Non Pregnant 
 
Likelihood to 
be 
misclassified: 
13.16% 
 
Predicated by 
Actual Ratio: 
HIV- : 16:18 
HIV+: 17:20 
Pregnant 
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Likelihood 
to be 
misclassified
: 17.86% 
 
Predicted by 
Actual ratio: 
HIV-: 16:18 
HIV+: 7:10 
 
The discriminant analysis conducted in respect volume misclassified only 5 women in the 
non-pregnant and pregnant each, totaling in 10 women misclassified. The table shows 
how the HIV positive and HIV negative congregate to their respective sides of the graph. 
Pregnancy seems to decrease the accuracy of classification.  
Type I interferon pathway 	 The	cytokines	from	our	study	associated	in	the	Type	I	Interferon	pathway	are	TRAIL,	IL-10,	IL-6,	IFN-ß,	MCP-1,	IFN-α2.	A	two	factor	ANOVA	shows	that	TRAIL,	IL-10,	and	IFN-α2	are	significantly	increased	in	HIV	positive	women.			 The	following	tables	show	the	Pearson	correlation	analysis	of	the	Type	I	IFN	associated	cytokines.			
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Table 16. Correlation matrix: HIV Negative, Non Pregnant, per ml 
	 IFN-b	 IL-6	(#2)	 IL-10	 MCP-1	 IFN-a2	 TRAIL	
IFN-b	 1.00	 -0.34	 -0.24	 0.19	 -0.07	 -0.27	
IL-6	(#2)	 -0.34	 1.00	 0.71	 0.23	 0.60	 0.81	
IL-10	 -0.24	 0.71	 1.00	 0.11	 0.51	 0.52	
MCP-1	 0.19	 0.23	 0.11	 1.00	 0.24	 0.33	
IFN-a2	 -0.07	 0.60	 0.51	 0.24	 1.00	 0.75	
TRAIL	 -0.27	 0.81	 0.52	 0.33	 0.75	 1.00		HIV-/NP	women	share	a	coefficient	greater	than	0.50	between	cytokines	IFN-α,	IL-6,	IL-10,	and	TRAIL.		
Table 17. Correlation matrix: HIV Negative, Pregnant, per ml 
	 IFN-b	 IL-6	(#2)	 IL-10	 MCP-1	 IFN-a2	 TRAIL	
IFN-b	 1.00	 0.08	 -0.16	 0.02	 0.00	 -0.16	
IL-6	(#2)	 0.08	 1.00	 0.08	 0.99	 0.53	 0.20	
IL-10	 -0.16	 0.08	 1.00	 0.13	 0.62	 -0.11	
MCP-1	 0.02	 0.99	 0.13	 1.00	 0.52	 0.11	
IFN-a2	 0.00	 0.53	 0.62	 0.52	 1.00	 0.42	
TRAIL	 -0.16	 0.20	 -0.11	 0.11	 0.42	 1.00	
 
The HIV-/Pregnant group’s correlations show that IL-10 decreased to less then 50% 
correlations with all cytokines in the pathway except for IFN-α2. IL-6 also shows a 
decrease in correlation under 50% with TRAIL as well as IL-10. MCP-1 also shows to 
share a correlation over 50% with IL-6 and with IFN-α2.  
Table 18. Correlation matrix: HIV Positive, Non Pregnant, per ml 
	 IFN-b	 IL-6	(#2)	 IL-10	 MCP-1	 IFN-a2	 TRAIL	
IFN-b	 1.00	 -0.06	 -0.07	 -0.06	 -0.06	 -0.15	
IL-6	(#2)	 -0.06	 1.00	 0.94	 0.29	 0.64	 0.22	
IL-10	 -0.07	 0.94	 1.00	 0.01	 0.51	 0.14	
MCP-1	 -0.06	 0.29	 0.01	 1.00	 0.44	 0.35	
IFN-a2	 -0.06	 0.64	 0.51	 0.44	 1.00	 0.81	
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TRAIL	 -0.15	 0.22	 0.14	 0.35	 0.81	 1.00	
 
The HIV+/NP group reflects the lack of correlation of IFN-b and MCP-1 with the other 
cytokines similar to the HIV-/NP group. In addition, TRAIL decreases its correlation to 
less than 50% with all the cytokines as well, with the exception of IFN-α2.  
Table 19. Correlation matrix: HIV Postive, Pregnant, per ml 
	 IFN-b	 IL-6	(#2)	 IL-10	 MCP-1	 IFN-a2	 TRAIL	
IFN-b	 1.00	 0.66	 -0.32	 0.53	 0.11	 0.46	
IL-6	(#2)	 0.66	 1.00	 0.10	 0.89	 0.80	 0.78	
IL-10	 -0.32	 0.10	 1.00	 0.33	 0.32	 -0.23	
MCP-1	 0.53	 0.89	 0.33	 1.00	 0.80	 0.64	
IFN-a2	 0.11	 0.80	 0.32	 0.80	 1.00	 0.65	
TRAIL	 0.46	 0.78	 -0.23	 0.64	 0.65	 1.00	
	The	HIV+/P	groups	show	a	correlation	greater	than	50%	for	IFB-ß	with	IL-6	and	with	MCP-1.	IL-10	decreases	in	correlation	with	all	the	cytokines	compared	to	the	HIV+/NP	group.	MCP-1	also	increases	in	correlation	with	all	cytokines	compared	to	the	HIV+/NP	group.								
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Figure 9. Clustered correlation matrices for Type I interferon Pathway. The 
following heat maps are of clustered correlation between cytokines involved in the Type I 
interferon pathway. The dark red indicates a perfect positive correlation (1), and the grey 
indicated a correlation coefficient of (0%), and dark blue indicates a perfect negative 
correlation (-1). A) Clustered correlation matrix of HIV negative/non pregnant subjects 
B) Clustered correlation matrix of HIV negative/pregnant subjects C) Clustered 
Correlation of HIV positive/ non pregnant subjects D) HIV positive/ Pregnant subjects 
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The shift between HIV-/NP	to	HIV-/P	group is apparent with the heat map, particularly 
MCP-1 increase in correlation with IL-6. Comparing the HIV+/P	group with the other 
groups, the heat map depicts an increase in correlation between most of type I IFN 
pathway associated cytokines. The following Spearman correlation analysis will 
determine whether the trends depicted about the type I IFN associated cytokines are 
significant or not.  
Table 20. Nonparametric: Spearman's ρ for HIV Negative, Non Pregnant subjects 
Variable by Variable Spearman ρ Prob>|ρ| Plot 
TRAIL MCP-1 0.1962 0.4353  
IL-10 MCP-1 0.1892 0.4520  
IL-10 TRAIL 0.7832 0.0001*  
IL-6 (#2) MCP-1 0.2897 0.2436  
IL-6 (#2) TRAIL 0.6936 0.0014*  
IL-6 (#2) IL-10 0.6034 0.0080*  
IFN-b MCP-1 0.1052 0.6779  
IFN-b TRAIL  -0.2655 0.2870  
IFN-b IL-10  -0.2614 0.2948  
IFN-b IL-6 (#2)  -0.1634 0.5170  
IFN-a2 MCP-1 0.2083 0.4069  
IFN-a2 TRAIL 0.8828 <.0001*  
IFN-a2 IL-10 0.7778 0.0001*  
IFN-a2 IL-6 (#2) 0.7527 0.0003*  
IFN-a2 IFN-b  -0.1331 0.5986  
* indicates that p ≤ 0.05 
The trend reported for group HIV-/NP is supported by the spearman analysis. All the 
cytokines except for IFN-b and MCP-1 associated correlations are significantly different 
from zero.  
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Table 21. Nonparametric: Spearman's ρ for HIV Negative, Pregnant Subjects 
Variable by Variable Spearman ρ Prob>|ρ| Plot 
TRAIL MCP-1 0.6706 0.0023*  
IL-10 MCP-1 0.4447 0.0645  
IL-10 TRAIL 0.6075 0.0075*  
IL-6 (#2) MCP-1 0.8347 <.0001*  
IL-6 (#2) TRAIL 0.6551 0.0032*  
IL-6 (#2) IL-10 0.2228 0.3742  
IFN-b MCP-1  -0.0445 0.8607  
IFN-b TRAIL  -0.1012 0.6894  
IFN-b IL-10  -0.0388 0.8784  
IFN-b IL-6 (#2) 0.1188 0.6386  
IFN-a2 MCP-1 0.6587 0.0030*  
IFN-a2 TRAIL 0.9335 <.0001*  
IFN-a2 IL-10 0.6764 0.0021*  
IFN-a2 IL-6 (#2) 0.6158 0.0065*  
IFN-a2 IFN-b 0.1415 0.5754  
* indicates that p ≤ 0.05 
The spearman correlation analysis for HIV-/P	group depicts a strong positive correlation 
between all cytokines except for IFN-ß. IL-10 fails to meet significance with MCP-1, and 
with IL-6. Overall the correlations that are significant are about 60%. The main 
difference with the HIV-/NP	group is the inclusion of MCP-1. The decrease in TRAIL’s 
correlations is not supported, the increase in MCP-1 linear association is supported, and 
the slight decrease in IL-10 seen in the Pearson analysis is supported here. 
Table 22. Nonparametric: Spearman’s ρ for HIV Positive, Non Pregnant Subjects 
Variable by Variable Spearman ρ Prob>|ρ| Plot 
TRAIL MCP-1 0.5288 0.0165*  
IL-10 MCP-1  -0.1033 0.6648  
IL-10 TRAIL 0.4113 0.0716  
IL-6 (#2) MCP-1 0.7283 0.0003*  
IL-6 (#2) TRAIL 0.6662 0.0013*  
IL-6 (#2) IL-10 0.1385 0.5604  
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Variable by Variable Spearman ρ Prob>|ρ| Plot 
IFN-b MCP-1 0.1759 0.4581  
IFN-b TRAIL 0.0382 0.8729  
IFN-b IL-10 0.0592 0.8042  
IFN-b IL-6 (#2) 0.2669 0.2553  
IFN-a2 MCP-1 0.6170 0.0038*  
IFN-a2 TRAIL 0.8058 <.0001*  
IFN-a2 IL-10 0.2953 0.2063  
IFN-a2 IL-6 (#2) 0.7823 <.0001*  
IFN-a2 IFN-b 0.2180 0.3559  
* indicates that p ≤ 0.05 The	HIV+/NP	group’s loss in strength of correlations is supported by the Spearman 
analysis. IL-10 is no longer significantly correlated with the type I interferon associated 
cytokines. Despite the correlations with IFN-α being significantly different from zero, the 
Spearman analysis depicts a loss in correlation magnitude when compared to the HIV-/NP	group.	 
	
Table	23:	Nonparametric: Spearman’s ρ for HIV Positive, Pregnant Subjects 
Variable by Variable Spearman ρ Prob>|ρ| Plot 
TRAIL MCP-1 0.6000 0.0667  
IL-10 MCP-1 0.3354 0.3435  
IL-10 TRAIL 0.2805 0.4325  
IL-6 (#2) MCP-1 0.9483 <.0001*  
IL-6 (#2) TRAIL 0.7295 0.0166*  
IL-6 (#2) IL-10 0.4098 0.2396  
IFN-b MCP-1 0.5000 0.3910  
IFN-b TRAIL 0.1000 0.8729  
IFN-b IL-10  -0.9487 0.0138*  
IFN-b IL-6 (#2) 0.2052 0.7406  
IFN-a2 MCP-1 0.7234 0.0180*  
IFN-a2 TRAIL 0.8450 0.0021*  
IFN-a2 IL-10 0.3609 0.3056  
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Variable by Variable Spearman ρ Prob>|ρ| Plot 
IFN-a2 IL-6 (#2) 0.8140 0.0042*  
IFN-a2 IFN-b 0.0513 0.9347  
* indicates that p ≤ 0.05 
The trend for the HIV+/P	group in the Pearson analysis is supported by the Spearman 
analysis. MCP-1, IFN-ß increased correlations are significant; IL-10 is no longer 
significantly correlated with TRAIL, IL-6, MCP-1, or IFN-α.  
Table 24: Discriminant analysis: Likelihood of HIV classification by Type I 
interferon pathway, concentration per ml. 
Non Pregnant 
 
Likelihood to be 
misclassified: 
21.05% 
 
Predicted by 
Actual Ratio: 
HIV- : 14:18 
HIV+: 16:20 
Pregnant 
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Likelihood to be 
misclassified: 32.14% 
 
Predicted by Actual 
Ratio: 
HIV- : 13:18 
HIV+: 6:10 
 
Pregnancy did not drastically change the amount of women misclassified, the percentage 
of likelihood does change by about 10%. These findings can be attributed to the number 
of subjects in the HIV+/P group. In the non pregnant analysis HIV serostatus is accurately 
classified about 78% of the time as oppose to roughly 68% percent in the pregnant group. 
Interferon Gamma Pathway 
The relevant cytokines known to be associated with the Interferon gamma pathway are 
IFN-γ, IL-12, IL-18, IL-2, IL-10. When adjusted for volume the following cytokines 
resulted in a positive association with HIV serostatus: IFN γ, IL-12, IL-2.  
Table 25. Correlation matrix: HIV Negative, Non Pregnant 
	 IFN-g	(#2)	 IL-12	 IL-18	 IL-2	 IL-10	
IFN-g	(#2)	 1.00	 0.79	 0.45	 0.30	 0.37	
IL-12	 0.79	 1.00	 0.34	 0.14	 0.52	
IL-18	 0.45	 0.34	 1.00	 0.09	 -0.02	
IL-2	 0.30	 0.14	 0.09	 1.00	 0.01	
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IL-10	 0.37	 0.52	 -0.02	 0.01	 1.00	
 
For the HIV-/NP group IL-12 is the only cytokine that shares a correlation greater than 
50% with more then one cytokine. IL -18 and IL-2 did not share any correlation greater 
than 50% with any of the interferon gamma associated cytokines.  
Table 26. Correlation matrix: HIV Negative, Pregnant 
	 IFN-g	(#2)	 IL-12	 IL-18	 IL-2	 IL-10	
IFN-g	(#2)	 1.00	 0.19	 0.56	 0.11	 0.24	
IL-12	 0.19	 1.00	 0.24	 -0.14	 -0.21	
IL-18	 0.56	 0.24	 1.00	 0.00	 0.11	
IL-2	 0.11	 -0.14	 0.00	 1.00	 0.83	
IL-10	 0.24	 -0.21	 0.11	 0.83	 1.00	
 The	HIV-/P	group depicts a shift in correlations away from IL-12 and towards IL-18 and 
IL-2. IL-18 and IFN-γ shared a correlation of 56%. IL-2 and IL-10 shared a correlation of 
83%. . 
Table 27. Correlation matrix: HIV Positive, Non Pregnant 
	 IFN-g	(#2)	 IL-12	 IL-18	 IL-2	 IL-10	
IFN-g	(#2)	 1.00	 0.51	 0.94	 0.76	 0.21	
IL-12	 0.51	 1.00	 0.38	 0.50	 0.38	
IL-18	 0.94	 0.38	 1.00	 0.69	 -0.05	
IL-2	 0.76	 0.50	 0.69	 1.00	 0.19	
IL-10	 0.21	 0.38	 -0.05	 0.19	 1.00	
 The	HIV+/NP	group shows a shift of correlation away from IL-10 and a strengthening of 
correlations with IFN-γ. Also IL-18 and IL- 2 have correlations greater than 50% with 
more than one other cytokine.  
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Table 28. Correlation matrix: HIV Positive, Pregnant 
	 IFN-g	(#2)	 IL-12	 IL-18	 IL-2	 IL-10	
IFN-g	(#2)	 1.00	 0.57	 0.32	 -0.35	 0.70	
IL-12	 0.57	 1.00	 0.31	 0.35	 0.58	
IL-18	 0.32	 0.31	 1.00	 0.18	 -0.29	
IL-2	 -0.35	 0.35	 0.18	 1.00	 -0.05	
IL-10	 0.70	 0.58	 -0.29	 -0.05	 1.00		The	HIV+/P	group shift the strength of correlations to IFN-γ, IL-12, and IL-10. This is a 
similar profile seen in HIV-/NP	group but greater in magnitude.  
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Figure 10. Clustered correlation matrices for Interferon gamma Pathway, per ml. 
The following heat maps are of clustered correlation between cytokines involved in the 
Type I interferon pathway. The dark red indicates a perfect positive correlation (1), and 
the grey indicated a correlation coefficient of (0%), and dark blue indicates a perfect 
negative correlation (-1). A) Clustered correlation matrix of HIV negative/non pregnant 
subjects B) Clustered correlation matrix of HIV negative/pregnant subjects C) Clustered 
Correlation of HIV positive/ non pregnant subjects D) HIV positive/ Pregnant subjects 
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The most distinguishable result in the heat maps is the increase in IL-18 correlation with 
IFN-γ. The increase in correlation between IFN-γ associated cytokines is visually 
depicted in the heat map.  
Table 29. Nonparametric: Spearman's ρ for HIV Negative, Non Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-12 IFN-g (#2) 0.7847 0.0001*  
IL-18 IFN-g (#2)  -0.1206 0.6335  
IL-18 IL-12 0.1831 0.4670  
IL-2 IFN-g (#2) 0.3892 0.1104  
IL-2 IL-12 0.2583 0.3008  
IL-2 IL-18  -0.1270 0.6155  
IL-10 IFN-g (#2) 0.4742 0.0468*  
IL-10 IL-12 0.4935 0.0374*  
IL-10 IL-18 0.2203 0.3798  
IL-10 IL-2 0.2897 0.2436  
 
The Spearman analysis supports the results from the Pearson correlations in the HIV-/NP 
group; IL-12, IL-10, and IFN-γ all share a significantly positive correlation.  
Table 30. Nonparametric: Spearman's ρ for HIV negative, Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-12 IFN-g (#2) 0.7530 0.0003*  
IL-18 IFN-g (#2) 0.5480 0.0185*  
IL-18 IL-12 0.5926 0.0095*  
IL-2 IFN-g (#2) 0.1415 0.5754  
IL-2 IL-12 0.2217 0.3766  
IL-2 IL-18 0.3054 0.2178  
IL-10 IFN-g (#2) 0.3379 0.1703  
IL-10 IL-12 0.3837 0.1160  
IL-10 IL-18 0.4052 0.0953  
IL-10 IL-2 0.8516 <.0001*  
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The HIV-/P group shows that there is continued correlation between IL-10 and IL-2 
despite the drop in correlation with the rest of the cytokines. This shift supports the shift 
witnessed in the Pearson analysis, a correlation shift away from IL-10 towards IL-18.  
The HIV-/P group’s Spearman analysis shows strong correlations between IFN-γ and IL-
18 and IL-12. 
Table 31. Nonparametric: Spearman's ρ for HIV Positive, Non Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-12 IFN-g (#2) 0.6454 0.0021*  
IL-18 IFN-g (#2) 0.6773 0.0010*  
IL-18 IL-12 0.4122 0.0709  
IL-2 IFN-g (#2) 0.4054 0.0762  
IL-2 IL-12 0.4097 0.0728  
IL-2 IL-18 0.2855 0.2224  
IL-10 IFN-g (#2) 0.3049 0.1912  
IL-10 IL-12 0.1933 0.4141  
IL-10 IL-18 0.0204 0.9321  
IL-10 IL-2 0.3545 0.1252  
 
The HIV+/NP group shows increase of greater than 50% in the correlations between IL-
18 and IFN- γ. The only other cytokine that retained a significant correlation was IL-12. 
Overall the HIV+/NP group underwent a dampening in correlation between the IFN-γ 
associated cytokines.  
Table 32. Nonparametric: Spearman's ρ for HIV Positive, Pregnant subjects 
Variable by 
Variable 
Spearman 
ρ 
Prob>|ρ| Plot 
IL-12 IFN-g (#2) 0.8149 0.0041*  
IL-18 IFN-g (#2) 0.5108 0.1313  
IL-18 IL-12 0.6505 0.0417*  
IL-2 IFN-g (#2)  -0.1111 0.7599  
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IL-2 IL-12 0.2378 0.5082  
IL-2 IL-18 0.0000 1.0000  
IL-10 IFN-g (#2) 0.7555 0.0115*  
IL-10 IL-12 0.4954 0.1454  
IL-10 IL-18 0.0366 0.9201  
IL-10 IL-2  -0.1590 0.6608  
 
This Spearman analysis supports the Pearson analysis, IL-12, IL-10, and IFN-γ are all 
significantly correlated and share a positive correlation.  
The discriminant analysis of pregnant and non-pregnant women shows a good 
clustering of the HIV negative population. The likelihood of correctly classifying HIV 
negative subject was 88.89%, while the likelihood to correctly classify HIV positive 
subjects was 50%, and 55% respectively.  
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Table 33: Discriminant analysis: Likelihood of HIV classification by Interferon 
gamma pathway, concentration per ml 
Non Pregnant 
 
Likelihood to be 
misclassified: 28.95% 
 
Predicted by Actual 
Ratio: 
HIV- : 15:18 
HIV+: 12:20 
Pregnant 
 
Likelihood to be 
misclassified: 25.00% 
 
Predicted by Actual 
Ratio: 
HIV- : 15:18 
HIV+: 6:10 
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DISCUSSION 
In this study we investigated whether HIV infection and pregnancy status in 
women affect vaginal inflammation (NF-KB pathway associated cytokines) or viral 
defense mechanisms (Interferon Type 1 and 2 pathway-associated cytokines). Some 
cytokines were detected in very low concentrations that may not be relevant in a 
physiological setting. However all cytokines were included in the correlation analysis if 
they were known to play a role in one of the pathways. The correlation of pathway-
associated cytokines could help link specific immune pathways with HIV serostatus 
and/or pregnancy, giving us insight on the immune environment in the cervical mucosa 
for specific sub groups of women. The NFκB pathway is a prominent inflammation 
pathway and is known to promote HIV transmission (Masson et al. 2014) due to a 
number of effects: 1) recruitment of HIV target cells to the epithelium due to expression 
of cytokines, 2) up regulation of HIV replication due to activation of the HIV LTR, and 
3) its role in increasing permeability of the epithelial layer (Nazli et al. 2010). If the HIV 
virus promotes a pro-inflammatory state, an up-regulation of the NFκB pathway would 
be expected. The Interferon pathways provide an important natural defense against 
viruses (Abbas, Lichtman, and Pillai 2014), they are associated with decreasing the 
infectivity of the HIV virus. We would expect to see this pathway upregulated in HIV 
infected women. Pregnancy has been shown to be associated with a proinflammatory 
state (Morrison et al. 2014). It is expected to see the NFκB pathway to be up regulated in 
pregnant women. 
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A number of statistical approaches were used to analyze the data. First, the 
Pearson correlation analysis compares the linear dependence between two variables, in 
this case cytokines, to dependent variables HIV serostatus and reproductive status. The 
value of the coefficient lies between -1/+1. 1 or -1 representing a perfect linear 
dependence between both variable and a 0 representing no linear dependence between the 
two cytokines in determining the dependent variable.  The correlation matrices will be 
composed of the same cytokines for each subgroup. If there is a change in linear 
dependence between cytokines across groups it will be visually distinguishable in a heat 
map, specifically a clustered heat map. This correlation analysis coupled with the known 
immunological pathways presents a form for us to visually represent activated immune 
pathways across the subgroups.  
Second, the Spearmen Rank correlation coefficient was used to measure whether 
the association between 2 variables was significantly non zero. It is extremely useful 
when either or both of the variables highly skewed as in our case. This allows us to 
incorporate the cytokines that were not able to be tested for significance but are known to 
participate in known pathways. The Pearson assumes normality and is typically used 
once significance has been established for the variable in question. The spearman test was 
useful in further confirming the change in correlations between groups was significant or 
not, and also associating cytokines that were left out of the original significance analysis. 
Third, the discriminant analysis was used as the final confirmatory method. It 
allows the use of known information of the dependent variables, in this case HIV 
serostatus and pregnancy. This priori information is one of the main conditions that 
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differentiate this analysis from a cluster analysis. The discriminant analysis uses the 
selected cytokine concentrations and determines whether the selected variables are 
effective in predicting the group a subject belongs to. Pairing this analysis with the 
pathway analysis previously explained could support the claim that the presence of 
expressed pathways is effective in distinguishing between groups.  
NFκB pathway 
To determine whether the NFκB pathway could be upregulated or down regulated 
by HIV infection or by pregnancy we analyzed the correlations of cytokines known to be 
associated in the NFκB pathway. From the ANOVA analysis we found that TNF-alpha, 
HGF, SCGF, and IL-10 increased significantly in HIV positive women. The correlation 
analysis will establish the dependence between the cytokines to argue an effect of HIV on 
the NFκB pathway. 
 The results support changes between the NFκB pathway associated cytokines. IL-
10 specifically is known as an anti-inflammatory cytokine, its role in dampening the 
inflammatory response is useful during inflammatory responses to prevent unwanted 
damage to tissue. The significant correlation with associated cytokines in the HIV 
negative non pregnant group also supports the role of IL-10 in immune homeostasis. 
Given that IL-10 also increases in HIV positive women, the absence of correlation with 
other significant NFκB associated cytokines suggests an inflammatory signal increasing 
faster than IL-10 concentrations, which would suppress inflammation. The significant 
increase in correlation between TNF-α with HGF, SCGF, IL-1b, TNF-b in HIV+/NP 
women compared to HIV-/NP women is further evidence that the NFκB pathway could 
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be upregulated in HIV positive women. This would also suggest that a proinflammatory 
state is present in HIV positive women. The correlations between TNF-α, TNF-β, IL-8 
and IL-1b can be explained by an increase in activation of M1 macrophages signaling an 
inflammatory response in HIV positive women. The correlations of HGF, SCGF, and IL-
1β with each other indicate that the cervical epithelial cells are playing a role in an 
immune response in HIV positive women. These findings are consistent with previous 
studies associating HIV with altering the female reproductive tract epithelium. Our study 
shows SCGF and HGF are both significantly increased in HIV positive women and 
positively correlated with the macrophage secreted cytokines. These results support the 
possible upregulation of the NFκB pathway in HIV positive women, and are consistent 
with previous studies implicating the association of NFκB in HIV infectivity (Masson et 
al. 2014).  
 There are some results that contradict the evidence for NFκB pathways 
association with HIV serostatus. IL-1α and IL-1ß are expressed by the same cells; their 
lack of correlation indicates that there might be an unforeseen variable affecting the 
concentrations. However, a similar unexpected trend occurred between the non-pregnant 
and pregnant, HIV negative groups. Pregnancy is known to be associated with a pro-
inflammatory state, this allows us to compare the correlation profile between HIV-/P and 
HIV+/NP groups. We expect both IL-1α and IL-1ß to be correlated. However, difficulty 
arises in comparing groups because pregnancy introduces several factors such as 
hormone regulation that have been shown to effect cytokine concentrations in the cervical 
mucosa. Some possible explanations for our inconsistent analysis findings are that 
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confounding variables could be present altering the concentrations for each group, or 
each group could be utilizing different inflammatory pathways. The mentionable 
similarities between the groups are the increases in correlations between macrophage 
associated cytokines and growth factors and the decrease in correlation of IL-10 with the 
other NFκB associated cytokines. The discriminant analysis explores the effect of 
pregnancy on classifying the serostatus. The high accuracy of both discriminant analysis 
supports our hypothesis of the involvement of the NFκB pathway in HIV positive women 
and pregnancy. The increase in accuracy between non-pregnant and pregnant could be 
signs of an up-regulation in the pathway as well. The small sample size of the HIV 
positive, pregnant group (n=10) decreases the power of the analysis. These findings are 
promising and could be strengthened with a larger sample size.  
Type I interferon Pathway 
The results of the Pearson correlation supports that the type I interferon pathway 
could be up regulated in HIV positive women. Our results only support the possible up 
regulation of the IFN-α pathway characterizing HIV positive women in an antiviral state. 
The correlation of IFN-α with other macrophage secreted cytokines (IL-6, IL-10), along 
with pro inflammatory cytokines (MCP-1, TRAIL) will strengthen the link between the 
antiviral state and the pro inflammatory state. Our results show a consistent significant 
correlation between TRAIL, IFN-α, and IL-6 across non pregnant women. IFN-ß is 
consistently not correlated with IFN-α, this could be explained by the source of the 
cytokines. While IFN-α is secreted by macrophages and dendritic cells, which are 
involved in the antiviral state, IFN-ß is secreted by fibroblasts which are involved in 
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activating NK-cells. This lack of correlation supports the presence of IFN-α mediated 
pathway instead of the general type I interferon pathway.  
The correlations between IL-6, IL-10 and IFN-α could be explained by the 
activation of macrophages and dendritic cells. The presence of MCP-1 could be 
indicative of T-cell, and dendritic cell signaling to infected tissue. T cell activation and 
macrophage activation are consistent with an antiviral, and proinflammatory state. These 
conditions are witnessed in the HIV positive non pregnant group of women. A similar 
trend is seen in the HIV negative group, with the exception that IL-10 is significantly 
correlated with the type I interferon-associated cytokines. IL-10 is a known inhibitor of 
IFN-α secreting cells, macrophages and dendritic cells. The lack of correlation of IL-10 
paired with the significant increase in IL-10 in HIV positive/ non pregnant women is 
further evidence supporting that the IFN-α antiviral pathway could be upregulated in HIV 
positive women.  
There are challenges to the interpretation of our data. The presence of correlation 
in pregnant women of IL-10 with the type I interferon-associates cytokines would imply 
that there is also a dampening of inflammation as well. Also the inflammatory markers, 
TRAIL, MCP-1, are not significantly increased in pregnancy to support their use as link a 
link between antiviral activity and inflammation seen in the HIV+/NP group. This 
interpretation contradicts the previous studies and evidence found in this study supporting 
that pregnancy is a proinflammatory state. This contradiction can be a result of using 
different inflammatory markers in this analysis.  
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The inclusion of other anti HIV activity markers such as SLPI, lactoferrin, and 
defensins may strengthen the argument for IFN-α involvement in HIV positive subjects. 
Including these antimicrobial peptides will also help distinguish the interpretation of the 
correlations between the role of IFN-α in pregnant women versus HIV positive women. 
Also including the CD4+ and CD8+ cell count in the analysis would strengthen the 
argument for an antiviral state. In conclusion, there is enough evidence to warrant further 
investigation on type I interferon’s involvement in HIV and pregnancy.  
IFN-γ   pathway 
Our analysis does not support the involvement of the IFN-γ pathway in HIV 
infection. A possible explanation could be the limited number of subjects. HIV infection 
induces the expression of interferons which are potent antiviral, however the reason why 
HIV is successful in proliferating in the body is because it has found ways to evade the 
immune system from detection. It is possible that some of our subjects were in viral 
latency (the dormant phase of the virus), which could explain the lack of IFN-γ 
correlations. Adjusting for viral load and/or CD4+/CD8+ cell count could be a method to 
control for this possibility.  
Our expectations were to associate the macrophage’s secretion of IL-18 and IL-12 
with the signaling for IFN-γ, and also associate IL-2 and IFN-γ due to their involvement 
with T cells. IL-2 is released by T cells to induce T cell activation and in turn IFN-γ is 
expressed by activated T cells to induce macrophage activation and an antibody response 
(Abbas, Lichtman, and Pillai 2014). Finally we looked to associate IL-10 with 
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macrophage secreted cytokines (IL-18,IL-12) due to its role in inhibiting macrophage 
production of IL-12 (Abbas, Lichtman, and Pillai 2014).  
Some expectations were consistent with our findings. IFN-γ was significantly 
correlated with IL-12 in all subgroups, which is expected because IL-12 acts on NK cells 
and T cells to produce IFN-γ and increase cytotoxicity (Abbas, Lichtman, and Pillai 
2014). Also IFN-γ and IL-18 are found to be significantly correlated in the HIV positive 
group of non pregnant women. These findings were consistent with an upregulation of 
IFN-γ by HIV infection. Moreover, IL-10 was no longer significantly correlated with 
IFN-γ in the HIV+/NP	group.	These	findings	along	with	the	significant	increase	in	IFN-γ,	IL-12,	and	IL-10	in	the	HIV+/NP	group	support	the	upregulation	of	the	IFN-γ	pathway	in	HIV	infection.	Inconsistencies	were	found	with	the	emergence	of	correlation	of	IL-10	in	the	HIV	positive,	pregnant	group.	This	could	however	be	attributed	to	the	sample	size	of	the	group	(N=10).		Moreover,	a	similar	trend	is	seen	in	the	HIV-/P	group.	Our	interpretation	of	the	results	would	conclude	that	pregnancy	would	also	show	signs	of	an	antiviral	state.	This	is	inconsistent	with	our	expectations	and	lead	us	to	assume	that	there	are	confounding	variables	present	altering	the	concentration.	Another	explanation,	which	supports	our	argument,	is	that	there	is	a	base	level	of	IFN-γ	concentration	present	at	all	times.	The	significant	correlation	of	IL-12	and	IL-18	with	IFN-γ	further	supports	their	interdependent	role	in	the	IFN-γ	pathway.	Moreover,	the	lack	of	significant	increase	in	IFN-γ	concentration	due	to	pregnancy	would	be	consistent	with	our	expectations	of	pregnancy	which	are	that	antiviral	mechanism	are	not	up-regulated. 
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 The effects of pregnancy on both HIV positive and negative women are 
inconclusive due to the limited number of subjects. However, the data shows that there 
might be a presence of the IFN-γ pathway. Increasing the number of HIV positive, 
pregnant participant is a strong first step in increasing the power of the analysis.  
Future experiments 
The similarities between HIV positive serostatus and pregnancy give reason to believe 
that both conditions up-regulate the inflammatory pathway. Other pathways worth 
investigating are MAP kinase pathway, and the TNF pathway. 
Conclusion 
This study focuses on utilizing the interdependent role of cytokines to explain 
physiological conditions seen in HIV infection and pregnancy. Identifying HIV infection 
as a proinflammatory state provides more understanding of HIV as a disease. It expands 
on the understanding of susceptibility to transmission and infection in the female genital 
tract, and could lead to identifying vulnerable populations. Overall our study shows 
evidence of a proinflammatory and a heightened antiviral environment in the HIV 
positive women. It also highlights that the proinflammatory state found in pregnant 
women is different from that in HIV positive women. We suspect this could be attributed 
to the contribution of different inflammatory pathways. We support the further 
investigation of inflammation’s role in HIV infection and how it is contributing to 
acquisition and transmission. 
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